Indication
Generalized Anxiety Disorder
4 registered trials testing LSD, Psilocybin, DMT for this indication, 1 recruiting now.
Sponsors register this under 2 different names, all collected here: Generalized Anxiety Disorder · Generalized Anxiety Disorder (GAD)
4
Registered trials
1
Recruiting
2
In Phase 3
Substances tested
Being studied with
Stay told
When a new trial opens
Trials
All 4 trials for Generalized Anxiety Disorder
| Trial | Status | Phase | Substance | Sites |
|---|---|---|---|---|
| Safety, Tolerability, and Preliminary Efficacy of Psilocybin Oral Solution in Adults With Generalized Anxiety DisorderNCT06969170 · Claudio N Soares | Recruiting | Phase 2 | psilocybin | 1 |
| A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)NCT06809595 · Definium Therapeutics US, Inc. | Active, not recruiting | Phase 3 | lsd | 36 |
| A Phase 3 Trial of DT120 for Generalized Anxiety Disorder (Voyage)NCT06741228 · Definium Therapeutics US, Inc. | Active, not recruiting | Phase 3 | lsd | 34 |
| A Study of a N, N-dimethyltryptamine (DMT) Analog (CYB004) in Participants With Generalized Anxiety Disorder (GAD)NCT06051721 · Cybin IRL Limited | Completed | Phase 2 | dmt | 6 |
Records from ClinicalTrials.gov API v2, data build 2026-08-25. Indications are the sponsors’ own words. LSD.com reports registered clinical research. It is not medical advice, it is not a recommendation to take any substance, and trial listings are not endorsements. Talk to a clinician.